Black Friday Sale: 20% off everything. Ends Tuesday 1 December, 11:59 pm AEDT.
For laboratory and research use only. Not for human consumption.  Sold exclusively to qualified researchers and licensed laboratories.

CATALOGUE  /  MOTS-C

MOTS-C 5MG

MOTS-C, lyophilised powder in a sealed vial

MOTS-C

Research peptide · Lyophilised powder in a sealed vial · for laboratory and research use only

MOTS-C 5mg Quantity per vial: 5mg
$89.99$71.99
Secure card payments
Not a drug, food or cosmetic. For laboratory and research use only. Not for human consumption. This product has not been evaluated or approved by the US Food and Drug Administration (FDA) or the Australian Therapeutic Goods Administration (TGA), and it is not intended to diagnose, treat, cure or prevent any disease. Sold exclusively to qualified researchers and licensed laboratories.

Reagent specifications

CAS number1627580-64-6
Molecular weight2174.6 g/mol (PubChem reference value)
StorageSealed, dry and dark at −20 °C or colder; −80 °C for long-term storage; warm to room temperature in a desiccator before opening
Certificate of analysisAvailable on request · Request a COA

CAS number and molecular weight are reference values for the compound identity, from PubChem.

Compound identity

Compound classMitochondrial-derived peptide (16 residues)
Full nameMitochondrial open reading frame of the 12S rRNA-c
Sequence (one-letter)MRWQEMGYIFYPRKLR
Molecular formulaC101H152N28O22S2 (PubChem)
PubChem CID146675088
OriginShort open reading frame in the mitochondrial 12S rRNA gene; first reported 2015
Supplied asLyophilised powder, sealed vial
Quantity per vial5 mg
Intended useLaboratory and research use only

About MOTS-C

MOTS-c is a 16-amino-acid peptide, MRWQEMGYIFYPRKLR, encoded by a short open reading frame in the mitochondrial genome, within the 12S rRNA gene, rather than by nuclear DNA.1 First reported in 2015, it belongs with humanin to the mitochondrial-derived peptides, and the name stands for mitochondrial open reading frame of the 12S rRNA-c.

Titan Peptides supplies MOTS-c as a lyophilised powder in a sealed 5 mg vial, for laboratory and research use only. It is a research chemical: not a drug, food or cosmetic, and not for human consumption.

Status in Australia

Australia's June 2026 Poisons Standard (F2026L00633) does not name MOTS-c.2 No MOTS-c product is an approved therapeutic good, and the research-grade material sold here is not one. How a product is supplied and presented also shapes its legal position; our guide to research peptides and Australian law sets out the framework.

Laboratory handling & storage

With two methionines and a tryptophan in its sequence, MOTS-c is prone to oxidation, so air, moisture and light all count. Store the vial sealed, dark, dry and frozen; supplier guidance runs from −20 °C for short periods to −80 °C for long-term storage. Warm it to room temperature inside a desiccator before opening so no condensation forms on the powder, then reseal promptly; for methionine- or tryptophan-containing sequences, flushing the headspace with nitrogen or argon is recommended. Solutions keep poorly: split a stock into single-use aliquots, freeze them and do not refreeze a thawed tube. More on storing lyophilised and reconstituted peptides and choosing a diluent for reconstitution.

MOTS-C quick answers

What form is MOTS-c supplied in?

MOTS-c is supplied as a lyophilised (freeze-dried) powder in a sealed vial containing 5 mg, for laboratory and research use only. It is a research chemical, not a drug, food or cosmetic, and is not for human consumption.

What is MOTS-c's CAS number?

PubChem lists MOTS-c under CAS number 1627580-64-6 and CID 146675088, with the sequence MRWQEMGYIFYPRKLR, the molecular formula C101H152N28O22S2 and a molar mass of 2174.6 g/mol. These identifiers let you match a vial, its documentation and the published literature to the same molecule.

Is MOTS-c legal in Australia?

MOTS-c does not appear by name in the June 2026 Poisons Standard, and no product containing it is an approved therapeutic good. A research label does not settle status: the Therapeutic Goods Act 1989 covers goods presented as, or likely to be taken as, being for therapeutic use. MOTS-c from Titan Peptides is sold for laboratory and research use only.

From the research library

Compound Profiles

MOTS-c: Compound Profile of a Mitochondrial-Derived Peptide

A chemical profile of MOTS-c, the 16-residue peptide encoded in the mitochondrial 12S rRNA gene: what a mitochondrial-derived peptide is, its identifiers, oxidation-prone residues and handling, and its status.

21 September 2026 · 3 min read
Lab Handling

How to Store Peptides: Lyophilised Powder and Solutions

A laboratory guide to storing lyophilised and reconstituted peptides: freezer temperatures, moisture, oxidation-prone residues, light, freeze–thaw cycles and adsorption to containers.

21 September 2026 · 7 min read

References

  1. PubChem. MOTS-c, CID 146675088. National Center for Biotechnology Information. Source
  2. Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 (Standard for the Uniform Scheduling of Medicines and Poisons No. 48), F2026L00633. Commenced 1 June 2026. Federal Register of Legislation. Source
Research use only. Not a drug, food or cosmetic. MOTS-C is supplied strictly for laboratory and in-vitro research and is not for human consumption. It is not an approved therapeutic good in Australia, has not been evaluated or approved by the FDA or the TGA, and is not intended to diagnose, treat, cure or prevent any disease. Titan Peptides sells exclusively to qualified researchers and licensed laboratories.